Abstract
Classical pharmaceutical research and development relies on the identification and validation of i) membranepermeable small molecules or ii) extracellular targets that are able to interfere with cellular key signaling pathways. During the last two decades the direct intracellular delivery of macromolecules developed into a novel paradigm to manipulate cell functions. This technique, commonly referred to as protein transduction, is based on the ability of certain peptides, designated as cell penetrating peptides (CPPs), to cross the cell membrane and deliver cargos such as peptides and proteins. Although protein transduction has been widely applied the process of cellular uptake remains poorly understood and therapeutic applications are rare thus far. The mechanism by which CPP-modified proteins adhere to, and cross the plasma membrane of cells as well as the subsequent intracellular trafficking is currently extensively investigated. While there is consent that CPP-cargos are internalized via endocytotic pathways the actual membrane translocation mechanism remains unclear. Recent studies indicate that CPP-cargo trapped in endosomal vesicles can be released into the cytosol by direct membrane perturbation or by retrograde delivery as demonstrated for various toxins. The present review seeks to outline the current state-of-the-art concerning the mechanism of protein transduction. A further mechanistic understanding will be critical to design transduction strategies that may open the door for cell-impermeable compounds to become intracellular effectors.
Keywords: Protein transduction, endocytosis, retrograde delivery, protein therapy
Current Pharmaceutical Design
Title: Protein Transduction Revisited: Novel Insights Into the Mechanism Underlying Intracellular Delivery of Proteins
Volume: 14 Issue: 34
Author(s): Frank Edenhofer
Affiliation:
Keywords: Protein transduction, endocytosis, retrograde delivery, protein therapy
Abstract: Classical pharmaceutical research and development relies on the identification and validation of i) membranepermeable small molecules or ii) extracellular targets that are able to interfere with cellular key signaling pathways. During the last two decades the direct intracellular delivery of macromolecules developed into a novel paradigm to manipulate cell functions. This technique, commonly referred to as protein transduction, is based on the ability of certain peptides, designated as cell penetrating peptides (CPPs), to cross the cell membrane and deliver cargos such as peptides and proteins. Although protein transduction has been widely applied the process of cellular uptake remains poorly understood and therapeutic applications are rare thus far. The mechanism by which CPP-modified proteins adhere to, and cross the plasma membrane of cells as well as the subsequent intracellular trafficking is currently extensively investigated. While there is consent that CPP-cargos are internalized via endocytotic pathways the actual membrane translocation mechanism remains unclear. Recent studies indicate that CPP-cargo trapped in endosomal vesicles can be released into the cytosol by direct membrane perturbation or by retrograde delivery as demonstrated for various toxins. The present review seeks to outline the current state-of-the-art concerning the mechanism of protein transduction. A further mechanistic understanding will be critical to design transduction strategies that may open the door for cell-impermeable compounds to become intracellular effectors.
Export Options
About this article
Cite this article as:
Edenhofer Frank, Protein Transduction Revisited: Novel Insights Into the Mechanism Underlying Intracellular Delivery of Proteins, Current Pharmaceutical Design 2008; 14 (34) . https://dx.doi.org/10.2174/138161208786898833
DOI https://dx.doi.org/10.2174/138161208786898833 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Improvement of Adoptive Cellular Immunotherapy of Human Cancer Using Ex-Vivo Gene Transfer
Current Gene Therapy Will Arsenic Trioxide Benefit Treatment of Solid Tumor by Nano- Encapsulation?
Mini-Reviews in Medicinal Chemistry Apoptosis in Drug Response
Current Pharmacogenomics Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Current Medicinal Chemistry The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design The Role of IRE1 Signaling in the Central Nervous System Diseases
Current Neuropharmacology Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Current Medicinal Chemistry Dual-Targeted Molecular Probes for Cancer Imaging
Current Pharmaceutical Biotechnology The Interplay between G-quadruplex and Transcription
Current Medicinal Chemistry Fungal Bioactive Compounds in Pharmaceutical Research and Development
Current Bioactive Compounds Posttranslational Regulation of O6-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers
Mini-Reviews in Medicinal Chemistry Small Interfering RNA for Effective Cancer Therapies
Mini-Reviews in Medicinal Chemistry Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology Natural Products as Anti-Invasive and Anti-Metastatic Agents
Current Medicinal Chemistry Role of CHK2 Inhibitors in the Cellular Responses to Ionizing Radiation
Mini-Reviews in Medicinal Chemistry A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development
Current Topics in Medicinal Chemistry Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening
Current Pharmaceutical Design The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology